Why Did iBio Shares Surge Over 11% In Pre-Market Trading?

Bio shares rose sharply after announcing upcoming presentations on its obesity treatment candidate at two industry ...
Fintel on MSN

Oppenheimer Initiates Coverage of iBio (IBIO) with Outperform Recommendation

Fintel reports that on October 21, 2025, Oppenheimer initiated coverage of iBio (NasdaqCM:IBIO) with a Outperform recommendation. Analyst Price Forecast Suggests 379.73% Upside As of September 30, ...
Fintel on MSN

Leerink Partners Initiates Coverage of iBio (IBIO) with Outperform Recommendation

Fintel reports that on October 17, 2025, Leerink Partners initiated coverage of iBio (NasdaqCM:IBIO) with a Outperform recommendation. Analyst Price Forecast Suggests 406.68% Upside As of September 30 ...

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Citigroup analyst Yigal Nochomovitz initiated coverage on ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) with a Buy rating and ...
Nasdaq

Leerink Partners Initiates Coverage of iBio (IBIO) with Outperform Recommendation

As of September 30, 2025, the average one-year price target for iBio is $4.28/share. The forecasts range from a low of $1.62 to a high of $6.30. The average price target represents an increase of ...